Novel Treatments for Neuromuscular Disorders

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). 

Spotlight

February 8, 2018 NEW STUDY SHOWS HOTSHOT® PROVIDES RELIEF FROM MUSCLE SORENESS FOR ATHLETES OF ALL TYPES
Read More

February 6, 2018 Flex Pharma Presenting at BIO CEO on February 13, 2018
Read More

November 28, 2017 Enrollment Completed in Flex Pharma’s Phase 2 Exploratory Spasticity Study in MS
Read More

November 6, 2017 Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in ALS
Read More